Trafermin 0.01% spray

DRUG2 trials

Sponsors

Olympus Biotech Corporation

Conditions

Diabetic Foot Ulcer of Neuropathic Origin

Phase 3

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study

CompletedNCT01217463

Olympus Biotech CorporationDiabetic Foot Ulcer of Neuropathic Origin

Start: 2010-11-30End: 2013-02-28Updated: 2014-08-05

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study

CompletedNCT01217476

Olympus Biotech CorporationDiabetic Foot Ulcer of Neuropathic Origin

Start: 2010-12-31End: 2013-03-31Updated: 2014-08-05